CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 727 enrolled
Drug / intervention
Adrenaline +1 moredrug
Likely dose
Adrenaline 1 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00358579
NCT00358579Phase 3Completed

A Randomised, Double-blinded Multi-centre Trial Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest at the Emergency Department. (Preadmission Intravenous Vasopressin, Adrenaline Outcome Trial: PIVOT vII)

Singapore General Hospital·interventional·Posted Aug 1, 2006·Updated Mar 17, 2017

In Brief

A Phase 3 clinical trial evaluating Adrenaline and Vasopressin for Cardiac Arrest. Completed, enrolled 727 participants across 4 sites.

Detailed Summary

The effectiveness of medications in cardiac arrest has been greatly debated and questioned. Historically intravenous adrenaline has been the drug of choice since 1906. There have been few formal evaluations to determine the value of adrenaline for cardiac arrest, and clinical trials have not been able to show any benefit with intravenous adrenaline (compared to placebo or no treatment) in the field. Thus the purpose of this study is to compare vasopressin and adrenaline in the treatment of cardiac arrest to answer the question whether there is an improvement in survival between vasopressin and adrenaline.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrest
CountriesSingapore

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 1, 2006
Enrollment StartMar 1, 2006
Primary CompletionJan 1, 2009
Study CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 19.9 years ago

Interventions

Adrenalinedrug

1 mg

Vasopressindrug

40 IU